BUZZ-Infinity Pharma 终止与 MEI Pharma 合并后股价下跌

Reuters
Jul 24, 2023

** Infinity Pharmaceuticals Inc 股价盘前下跌约43%至0.12美元

** 该公司称 (link) 它已终止与癌症疗法开发商 MEI Pharma Inc 的合并协议

** 称 MEIP 股东不同意与英飞尼迪合并

** INFI称将探索战略替代方案,以实现其主要候选药物eganelisib的潜在价值

** Eganelisib 正在一项针对一种头颈部癌症的中期研究中接受测试 - INFI

** INFI 有权从 MEIP 报销 100 万美元的某些开支和费用,根据合并协议的条款,INFI 还有资格再获得400 万美元- INFI

** 截至上次收盘,INFI 的股价今年下跌了约 60

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10